20 LATEST RESOURCES (10 INDEXED)
×
Use of Fluphenazine in Bipolar Disorder with a History of Substance Abuse: A Report of Two Cases · January 2023
Articles
Cureus
×
Antiviral Activity of Chlorpromazine, Fluphenazine, Perphenazine, Prochlorperazine, and Thioridazine Towards RNA-Viruses: A Review · September 2020
Articles
NCBI>European Journal of Pharmacology
×
A Review of a Recently Published Guidelines’ “Strong Recommendation” for Therapeutic Drug Monitoring of Olanzapine, Haloperidol, Perphenazine, and Fluphenazine · July 2019
Articles
Mental Health Clinician
×
Fluphenazine (Oral) versus Placebo for Schizophrenia · June 2018
Articles
Cochrane Database of Systematic Reviews
×
Cardiovascular Risks of Fluphenazine in a Patient with Schizophrenia · April 2018
Articles
NCBI>Journal of Pharmacy Technology
×
Fluphenazine (Oral) versus Atypical Antipsychotics for Schizophrenia · July 2016
Articles
Cochrane Database of Systematic Reviews
×
Fluphenazine Decanoate (Depot) and Enanthate for Schizophrenia · February 2015
Articles
Cochrane Database of Systematic Reviews
×
Effectiveness of Switching from Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial · May 2012
Abstracts
Journal of Clinical Psychiatry
×
Number Needed to Treat and Number Needed to Harm with Paliperidone Palmitate Relative to Long-Acting Haloperidol, Bromperidol, and Fluphenazine Decanoate for Treatment of Patients with Schizophrenia · March 2011
Articles
Neuropsychiatric Disease and Treatment
×
Treatment of Schizophrenia with Long-Acting Fluphenazine, Haloperidol, or Risperidone · April 2007
Articles
Schizophrenia Bulletin